Fresenius Medical Care AG & Co. KGaA (Germany) and DaVita Inc. (US) are Leading players in the Hemodialysis and Peritoneal Dialysis Market
The global hemodialysis and peritoneal dialysis market is projected to reach USD 126.2 billion by 2029 from USD 92.0 billion in 2024 at a CAGR of 6.5% during the forecast period.
The global rising prevalence of end-stage renal disease (ESRD), growth in aging populations, ongoing healthcare infrastructure investments in developing countries, expansion of hemodialysis and peritoneal dialysis services, growing awareness of the advantages of home dialysis, rising technological advancements and new product launch by key players are anticipated to propel the hemodialysis and peritoneal dialysis market growth during the forecast period. However, high cost associated with hemodialysis and peritoneal dialysis treatment can become barriers to access to patients in low-income countries with poor healthcare infrastructure. Additionally, product recall can pose a significant challenge to market players.
To know about the assumptions considered for the study download the pdf brochure
The hemodialysis and peritoneal dialysis market is a consolidated market. Some of the prominent players operating in the market include Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International, Inc. (US), Nipro Corporation (Japan), Nikkiso Co., Ltd. (Japan), Diaverum (Germany), B. Braun Melsungen AG (Germany), Asahi Kasei Corporation (Japan), DaVita Inc. (US), Medtronic plc (Ireland), Rockwell Medical, Inc. (US), Becton, Dickinson, and Company (US), Dialife SA (Switzerland), and Isopure Corp. (US).
Fresenius Medical Care AG
Fresenius Medical Care AG is one of the world’s largest providers of renal care products and services. The company has a wide range of hemodialysis and peritoneal dialysis equipment and services offerings. The company focuses mainly on agreements and partnerships with market players and dialysis centers and to expand its product offerings in the global dialysis market. In 2023, 16% of dialysis treatments in the United States were conducted in patients' homes using Fresenius dialysis products, aiming to increase the proportion of dialysis treatments performed at home to 25% by 2027. It has a strong research and development activities towards developing innovative renal care products and therapies, regenerative medicines that meet high quality standards. Additionally, the company aims to leverage digital technologies like artificial intelligence and big data analytics to create innovative care models for individuals suffering from kidney disease.
DaVita Inc.
DaVita Inc. is a leading player in the global dialysis services market. DaVita operates a vast network of outpatient dialysis centers across the United States and in several other countries. The company mainly focuses on patient retention and the expansion of its business in the global dialysis market. Due to its excellent financial position, the company has managed to acquire more than 100 dialysis centers globally, thus driving the growth of the dialysis services market in the emerging Asia Pacific region.
Related Reports:
Hemodialysis and Peritoneal Dialysis Market by Product (Machine, Bloodline, Concentrate (Alkaline), Catheter, Dialyzer, Water Treatment, Services), Modality (CAPD, Nocturnal), User (Hospital, Home Care) - Global Forecast to 2029
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
